CSL signs deal with Trump administration to slash prices for its medicines
Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.watoday.com.au — the content belongs to WAtoday.
